<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>IUIS classification of combined immunodeficiencies with associated or syndromic features (category II inborn errors of immunity)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">IUIS classification of combined immunodeficiencies with associated or syndromic features (category II inborn errors of immunity)</h1>
<div class="graphic"><div class="figure"><div class="ttl">IUIS classification of combined immunodeficiencies with associated or syndromic features (category II inborn errors of immunity)</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="10%"></colgroup> <colgroup span="1" width="30%"></colgroup> <tbody> <tr> <td class="subtitle1">Disease</td> <td class="subtitle1">Genetic defect</td> <td class="subtitle1">Inheritance</td> <td class="subtitle1">OMIM</td> <td class="subtitle1">T cells</td> <td class="subtitle1">B cells</td> <td class="subtitle1">Immunoglobulin</td> <td class="subtitle1">Associated features</td> </tr> <tr> <td class="subtitle2_left" colspan="8">Immunodeficiency with congenital thrombocytopenia</td> </tr> <tr> <td class="indent1">Wiskott-Aldrich syndrome (WAS LOF)</td> <td>WASP actin nucleation promoting factor (<em>WAS</em>)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/300392" target="_blank">300392</a></td> <td>Progressive decrease in numbers; abnormal lymphocyte responses to anti-CD3</td> <td>Normal numbers</td> <td>Low IgM and antibody responses to polysaccharides; often high IgA and IgE</td> <td>Thrombocytopenia with small platelets, eczema, recurrent bacterial/viral infections, blood diarrhea, lymphoma, autoimmune disease IgA nephropathy; patients with XL thrombocytopenia have later onset of complications and more favorable life expectancy but eventually develop similar complications as observed in WAS</td> </tr> <tr> <td class="indent1">WIP deficiency</td> <td>WAS/WASL interacting protein family member 1 (<em>WIPF1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602357" target="_blank">602357</a></td> <td>Reduced, defective lymphocyte responses to anti-CD3</td> <td>Normal or low</td> <td>Normal, except for high IgE</td> <td>Thrombocytopenia with or without small platelets, recurrent bacterial and viral infections, eczema, bloody diarrhea, WAS protein absent</td> </tr> <tr> <td class="indent1">Arp2/3-mediated filament branching defect</td> <td>Actin-related protein 2/3 complex subunit 1B (<em>ARPC1B</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/604223" target="_blank">604223</a></td> <td>Normal</td> <td>Normal numbers</td> <td>Normal, except for high IgA and IgE</td> <td>Mild thrombocytopenia with normal-sized platelets, recurrent invasive infections, colitis, vasculitis, autoantibodies (ANA, ANCA), eosinophilia, defective Arp2/3 filament branching</td> </tr> <tr> <td class="subtitle2_left" colspan="8">DNA repair defects other than those classified as category I IEI</td> </tr> <tr> <td class="indent1">Ataxia-telangiectasia</td> <td>ATM serine/threonine kinase (<em>ATM</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/607585" target="_blank">607585</a></td> <td>Progressive disease; poor proliferation to mitogens; may have low TRECs and T cells by NBS</td> <td>Normal</td> <td>Often low IgA, IgE, and IgG; increased IgM monomers; antibodies variably decreased</td> <td>Ataxia; telangiectasia, especially of sclerae; pulmonary infections; lymphoreticular and other malignancies; increased alpha fetoprotein; increased radiosensitivity, chromosomal instability, and chromosomal translocations</td> </tr> <tr> <td class="indent1">Nijmegen breakage syndrome</td> <td>Nibrin (<em>NBN</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602667" target="_blank">602667</a></td> <td>Progressive disease; may have low TRECs and T cells by NBS</td> <td>Variably reduced</td> <td>Often low IgA, IgE, and IgG subclasses; increased IgM; antibodies variably decreased</td> <td>Microcephaly, dysmorphic facies, lymphomas and solid tumors, increased radiosensitivity, chromosomal instability</td> </tr> <tr> <td class="indent1">Bloom syndrome</td> <td>BLM RecQ-like helicase (<em>BLM</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/604610" target="_blank">604610</a></td> <td>Normal</td> <td>Normal</td> <td>Low</td> <td>Short stature, dysmorphic facies, sun-sensitive erythema, marrow failure, leukemia, lymphoma, chromosomal instability</td> </tr> <tr> <td class="indent1" rowspan="4">Immunodeficiency with centromeric instability and facial anomalies (ICF types 1, 2, 3, 4)</td> <td>DNA methyltransferase 3 beta (<em>DNNMT3B</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602900" target="_blank">602900</a></td> <td>Decreased or normal; responses to PHA may be decreased</td> <td>Decreased or normal</td> <td>Hypogammaglobulinemia or agammaglobulinemia; variable antibody deficiency</td> <td>Facial dysmorphic features, developmental delay, macroglossia, bacterial/opportunistic infections, malabsorption, cytopenias, malignancies, multiradial configurations of chromosomes 1, 9, 16</td> </tr> <tr> <td>Zinc finger and BTB domain containing 24 (<em>ZBTB24</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/614064" target="_blank">614064</a></td> <td>Decreased or normal</td> <td>Decreased or normal</td> <td>Hypogammaglobulinemia or agammaglobulinemia; variable antibody deficiency</td> <td>Facial dysmorphic features, macroglossia, bacterial/opportunistic infections, malabsorption, cytopenias, malignancies, multiradial configurations of chromosomes 1, 9, 16</td> </tr> <tr> <td>Cell division cycle associated 7 (<em>CDCA7</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/609937" target="_blank">609937</a></td> <td>Decreased or normal; responses to PHA may be decreased</td> <td>Decreased or normal</td> <td>Hypogammaglobulinemia or agammaglobulinemia; variable antibody deficiency</td> <td>Facial dysmorphic features, macroglossia, bacterial/opportunistic infections, malabsorption, cytopenias, malignancies, multiradial configurations of chromosomes 1, 9, 16</td> </tr> <tr> <td>Helicase, lymphoid specific (<em>HELLS</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/603946" target="_blank">603946</a></td> <td>Decreased or normal</td> <td>Decreased or normal</td> <td>Hypogammaglobulinemia or agammaglobulinemia; variable antibody deficiency</td> <td>Facial dysmorphic features, macroglossia, bacterial/opportunistic infections, malabsorption, cytopenias, malignancies, multiradial configurations of chromosomes 1, 9, 16</td> </tr> <tr> <td class="indent1">PMS2 deficiency</td> <td>Phytohemagglutinin PMS1 homolog 2, mismatch repair system component (<em>PMS2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/600259" target="_blank">600259</a></td> <td>Normal</td> <td>Low B cells, switched and nonswitched</td> <td>Low IgG and IgA; high IgM; abnormal antibody responses </td> <td>Recurrent infections, <em>café-au-lait</em> spots, lymphoma, colorectal carcinoma, brain tumors</td> </tr> <tr> <td class="indent1">RNF168 deficiency (radiosensitivity, immune deficiency, dysmorphic features, learning difficulties [RIDDLE] syndrome)</td> <td>Ring finger protein 168 (<em>RNF168</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/612688" target="_blank">612688</a></td> <td>Normal</td> <td>Normal</td> <td>Low IgG or IgA</td> <td>Short stature, mild defect of motor control to ataxia, normal intelligence to learning difficulties, mild facial dysmorphism to microcephaly, increased radiosensitivity</td> </tr> <tr> <td class="indent1">MCM4 deficiency</td> <td>Minichromosome maintenance complex component 4 (<em>MCM4</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602638" target="_blank">602638</a></td> <td>Normal</td> <td>Normal</td> <td>Normal</td> <td>Low number and function of NK cells, viral infections (EBV, HSV, VZV), short stature, B cell lymphoma, adrenal failure</td> </tr> <tr> <td class="indent1">X-linked reticulate pigmentary disorder (POLA1 deficiency)</td> <td>DNA polymerase alpha 1, catalytic subunit (<em>POLA1</em>)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/301220" target="_blank">301220</a></td> <td>Not assessed</td> <td>Not assessed</td> <td>Not assessed</td> <td>Hyperpigmentation, characteristic facies, lung and GI involvement</td> </tr> <tr> <td class="indent1">Polymerase epsilon subunit 1 (POLE1) deficiency (FILS syndrome)</td> <td>DNA polymerase epsilon, catalytic subunit (<em>POLE</em>) </td> <td>AR</td> <td><a href="https://www.omim.org/entry/174762" target="_blank">174762</a></td> <td>Normal; decreased T cell proliferation</td> <td>Low memory B cells</td> <td>Low IgG2 and IgM; lack of antibody to polysaccharides</td> <td>Recurrent respiratory infections, meningitis, facial dysmorphism, livedo, short stature</td> </tr> <tr> <td class="indent1">Polymerase epsilon subunit 2 (POLE2) deficiency</td> <td>DNA polymerase epsilon 2, accessory subunit (<em>POLE2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602670" target="_blank">602670</a></td> <td>Lymphopenia; lack of TRECs at NBS; absent proliferation in response to antigens</td> <td>Very low</td> <td>Hypogammaglobulinemia</td> <td>Recurrent infections, disseminated BCG infections, autoimmunity (type 1 diabetes), hypothyroidism, facial dysmorphism</td> </tr> <tr> <td class="indent1">Ligase I deficiency</td> <td>DNA ligase 1 (<em>LIG1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/126391" target="_blank">126391</a></td> <td>Lymphopenia; increased gamma-delta T cells; decreased mitogen response</td> <td>Normal</td> <td>Hypogammaglobulinemia; reduced antibody responses</td> <td>Recurrent bacterial and viral infections, growth retardation, sun sensitivity, radiation sensitivity, macrocytic RBCs</td> </tr> <tr> <td class="indent1">NSMCE3 deficiency</td> <td>NSE3 homolog, SMC5-SMC6 complex component (<em>NSMCE3</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/608243" target="_blank">608243</a></td> <td>Decreased number; poor responses to mitogens an antigens</td> <td>Normal</td> <td>Normal IgG and IgA; normal to elevated IgM; decreased antibody responses to polysaccharides</td> <td>Severe lung disease (possibly viral), thymic hypoplasia, chromosomal breakage, radiation sensitivity</td> </tr> <tr> <td class="indent1">ERCC6L2 (Hebo) deficiency</td> <td>ERCC excision repair 6-like 2 (<em>ERCC6L2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615667" target="_blank">615667</a></td> <td>Lymphopenia</td> <td>Low</td> <td>Normal</td> <td>Facial dysmorphism, microcephaly, bone marrow failure</td> </tr> <tr> <td class="indent1">GINS1 deficiency</td> <td>GINS complex subunit 1 (<em>GINS1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/610608" target="_blank">610608</a></td> <td>Low or normal</td> <td>Low or normal</td> <td>High IgA; low IgM and IgG</td> <td>Neutropenia, IUGR, NK cells very low</td> </tr> <tr> <td class="indent1">MCM10 deficiency</td> <td>Minichromosome maintenance 10 replication initiation factor (<em>MCM10</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/619313" target="_blank">619313</a></td> <td>Low or normal</td> <td>Low</td> <td>Normal IgM and IgA; decreased IgG</td> <td>Severe (fatal) CMV infection, HLH-like, phenocopies <em>GINS1</em> and <em>MCM4</em> deficiencies, low NK cells and NK function</td> </tr> <tr> <td class="subtitle2_left" colspan="8">Thymic defects with additional congenital anomalies</td> </tr> <tr> <td class="indent1">DiGeorge/velocardiofacial syndrome chromosome 22q11.2 deletion syndrome (22q11.2DS)</td> <td>Large deletion (3 Mb), typically in chromosome 22 (T-box transcription factor 1 [<em>TBX1</em>])</td> <td>AD</td> <td><a href="https://www.omim.org/entry/602054" target="_blank">602054</a></td> <td>Decreased or normal; 5% have low TRECs at NBS and &gt;1500 CD3T cells/uL in neonatal period</td> <td>Normal</td> <td>Normal or decreased</td> <td>Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability</td> </tr> <tr> <td class="indent1">DiGeorge/velocardiofacial syndrome</td> <td>Unknown</td> <td>Sporadic</td> <td> </td> <td>Decreased or normal</td> <td>Normal</td> <td>Normal or decreased</td> <td>Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability</td> </tr> <tr> <td class="indent1">TBX1 deficiency</td> <td>T-box transcription factor 1 (<em>TBX1</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/602054" target="_blank">602054</a></td> <td>Decreased or normal; may have low TRECs at NBS</td> <td>Normal</td> <td>Normal or decreased</td> <td>Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability</td> </tr> <tr> <td class="indent1" rowspan="3">CHARGE syndrome</td> <td>Chromodomain helicase DNA binding protein 7 (<em>CHD7</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/608892" target="_blank">608892</a></td> <td>Decreased or normal; may have low TRECs at NBS; response to PHA may be decreased</td> <td>Normal</td> <td>Normal or decreased</td> <td>Colomba of eye, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies, CNS malformation, some are SCID-like</td> </tr> <tr> <td>Semaphorin 3E (<em>SEMA3E</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/608166" target="_blank">608166</a></td> <td>Decreased or normal; may have low TRECs at NBS; response to PHA may be decreased</td> <td>Normal</td> <td>Normal or decreased</td> <td>Colomba of eye, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies, CNS malformation, some are SCID-like</td> </tr> <tr> <td>Unknown</td> <td> </td> <td> </td> <td>Decreased or normal; may have low TRECs at NBS; response to PHA may be decreased</td> <td>Normal</td> <td>Normal or decreased</td> <td>Colomba of eye, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies, CNS malformation, some are SCID-like</td> </tr> <tr> <td class="indent1">Winged helix nude FOXN1 deficiency</td> <td>Forkhead box N1 (<em>FOXN1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/601705" target="_blank">601705</a></td> <td>Very low</td> <td>Normal</td> <td>Decreased</td> <td>Severe infections, abnormal thymic epithelium, immunodeficiency, congenital alopecia, nail dystrophy, neural tube defect</td> </tr> <tr> <td class="indent1">FOXN1 haploinsufficiency</td> <td>Forkhead box N1 (<em>FOXN1</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/600838" target="_blank">600838</a></td> <td>Severe T cell lymphopenia at birth, normalized by adulthood</td> <td>Normal/low</td> <td>Not assessed</td> <td>Recurrent viral and bacterial respiratory tract infections, skin involvement (eczema, dermatitis), nail dystrophy</td> </tr> <tr> <td class="indent1">Chromosome 10p13-p14 deletion syndrome (10p13-p14DS)</td> <td>Del10p13-p14</td> <td>AD</td> <td><a href="https://www.omim.org/entry/601362" target="_blank">601362</a> </td> <td>Normal; rarely, lymphopenia and decreased lymphoproliferation to mitogens an antigens; hypoplastic thymus may be present</td> <td>Normal</td> <td>Normal</td> <td>Hypoparathyroidism, kidney disease, deafness, growth retardation, facial dysmorphism, cardiac defects may be present, recurrent infections may be present</td> </tr> <tr> <td class="indent1">Chromosome 11q deletion syndrome (Jacobsen syndrome)</td> <td>11q23del</td> <td>AD</td> <td><a href="https://www.omim.org/entry/147791" target="_blank">147791</a></td> <td>Lymphopenia; low NK cells</td> <td>Decreased B cells and switched memory B cells</td> <td>Hypogammaglobulinemia; decreased antibody responses</td> <td>Recurrent respiratory infections, multiple warts, facial dysmorphism, growth retardation</td> </tr> <tr> <td class="subtitle2_left" colspan="8">Immunoosseous dysplasias</td> </tr> <tr> <td class="indent1">Cartilage-hair hypoplasia (CHH)</td> <td>RNA component of mitochondrial RNA processing endoribonuclease (<em>RMRP</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/157660" target="_blank">157660</a></td> <td>Varies from severely decreased (SCID) to normal; impaired lymphocyte proliferation</td> <td>Normal</td> <td>Normal or reduced; antibodies variably decreased</td> <td>Short-limed dwarfism with metaphyseal dysostosis, sparse hair, one marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine</td> </tr> <tr> <td class="indent1">Schimke immunoosseous dysplasia</td> <td>SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 (<em>SMARCAL1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/606622" target="_blank">606622</a></td> <td>Decreased</td> <td>Normal</td> <td>Normal</td> <td>Short stature; spondyloepiphyseal dysplasia; IUGR; nephropathy; bacterial, viral, and fungal infections; may present as SCID; bone marrow failure</td> </tr> <tr> <td class="indent1">MYSM1 deficiency</td> <td>Myb-like, SWIRM and MPN domains 1 (<em>MYSM1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/612176" target="_blank">612176</a></td> <td>T cell lymphopenia; reduced naïve T cells; low NK cells</td> <td>B cell deficiency</td> <td>Hypogammaglobulinemia</td> <td>Short stature, recurrent infections, congenital bone marrow failure, myelodysplasia, immunodeficiency affecting B cells and granulocytes, skeletal anomalies, cataracts, developmental delay</td> </tr> <tr> <td class="indent1">MOPD1 deficiency (Roifman syndrome)</td> <td>RNA, U4atac small nuclear (<em>RNU4ATAC</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/601428" target="_blank">601428</a></td> <td>Decreased NK cell function</td> <td>Decreased total and memory B cells</td> <td>Hypogammaglobulinemia; variably decreased specific antibodies</td> <td>Recurrent bacterial infections, lymphadenopathy, spondyloepiphyseal dysplasia, extreme IUGR, retinal dystrophy, facial dysmorphism, may present with microcephaly, short stature</td> </tr> <tr> <td class="indent1">Immunoskeletal dysplasia with neurodevelopmental abnormalities (EXTL3 deficiency)</td> <td>Exostosin-like glycosyltransferase 3 (<em>EXTL3</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/617425" target="_blank">617425</a></td> <td>Decreased</td> <td>Normal</td> <td>Decreased to normal</td> <td>Short stature, cervical spinal stenosis, neurodevelopmental impairment, eosinophilia, may have early infant mortality</td> </tr> <tr> <td class="subtitle2_left" colspan="8">Hyper-IgE syndromes (HIES)</td> </tr> <tr> <td class="indent1">AD-HIES STAT3 deficiency (Job syndrome)</td> <td>Signal transducer and activator of transcription 3 (<em>STAT3</em>)</td> <td>AD LOF (DN)</td> <td><a href="https://www.omim.org/entry/147060" target="_blank">147060</a></td> <td>Normal overall; Th17, T follicular helper, MAIT, NKT cells decreased; Tregs may be increased; impaired responses to STAT3-activating cytokines</td> <td>Normal; reduced memory B cells; BAFF expression increased; impaired response to STAT3-activating cytokines</td> <td>Very high IgE; specific antibody production decreased</td> <td>Distinctive facial features (broad nasal bridge); bacterial infections (boils, pulmonary abscesses, pneumatoceles) due to <em>Staphylococcus aureus</em>, pulmonary <em>Aspergillus</em>, <em>Pneumocystis jirovecii</em>; eczema; mucocutaneous candidiasis; hyperextensible joins; osteoporosis and bone fractures; scoliosis; retained primary teeth; coronary and cerebral aneurysms</td> </tr> <tr> <td class="indent1">IL-6 receptor deficiency</td> <td>IL-6 receptor (<em>IL6R</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/147880" target="_blank">147880</a></td> <td>Normal/increased; normal responses to mitogens</td> <td>Normal total memory B; reduced switched memory B</td> <td>Normal/low serum IgM, IgG, and IgA; very high IgE; specific antibody production low</td> <td>Recurrent pyogenic infections, cold abscesses, high circulating IL-6 levels</td> </tr> <tr> <td class="indent1" rowspan="2">IL-6 signal transducer (IL6ST) deficiency (partial)</td> <td rowspan="2">IL-6 cytokine family signal transducer (<em>IL6ST</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/618523" target="_blank">618523</a></td> <td>Decreased Th17 cells</td> <td>Reduced switched and nonswitched memory B cells</td> <td>High IgE; specific antibody production variably affected</td> <td>Bacterial infections, boils, eczema, pulmonary abscesses, pneumatoceles, bone fractures, scoliosis, retained primary teeth, craniosynostosis</td> </tr> <tr> <td>AD</td> <td><a href="https://www.omim.org/entry/619752" target="_blank">619752</a></td> <td>Normal; increased naïve; increased Th2</td> <td>Normal total but reduced memory</td> <td>Normal IgM, IgG, and IgA; hyper-IgE</td> <td>Dermatitis/eczema, eosinophilia, recurrent skin infections, pneumonia, bronchiectasis, pneumatoceles with severe secondary pulmonary aspergillosis, connective tissue defects (scoliosis, face, joins, fractures, palate, tooth retention), phenocopies aspects of IL-6R and IL-11R deficiencies (due to unresponsiveness to these cytokines) as well as STAT3 DN/AR ZNF341</td> </tr> <tr> <td class="indent1">IL6ST deficiency (complete)</td> <td>IL-6 cytokine family signal transducer (<em>IL6ST</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/619751" target="_blank">619751</a></td> <td colspan="3">No data; death in utero or in neonatal period occurred for most affected individuals</td> <td>Fatal Stuve-Wiedemann-like syndrome, skeletal dysplasia, osteoporosis, hyperextensibility, lung dysfunction, kidney abnormalities, thrombocytopenia, dermatitis, eczema, defective acute-phase response, completely unresponsive to IL-6 family cytokines</td> </tr> <tr> <td class="indent1">ZNF341 deficiency (AR-HIES)</td> <td>Zinc finger protein 341 (<em>ZNF341</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/618282" target="_blank">618282</a></td> <td>Decreased Th17 and NK cells</td> <td>Normal; reduced memory B cells; impaired response to STAT3-activating cytokines</td> <td>High IgE and IgG; specific antibody production decreased</td> <td>Phenocopy of AD-HIES, mild facial dysmorphism, early-onset eczema, mucocutaneous candidiasis, bacterial skin infections, abscesses, recurrent bacterial respiratory infections (<em>S. aureus</em>), lung abscesses and pneumatoceles, hyperextensible joints, bone fractures and retained primary teeth</td> </tr> <tr> <td class="indent1">ERBIN deficiency</td> <td>Erbb2-interacting protein (<em>ERBIN</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/606944" target="_blank">606944</a></td> <td>Increased circulating Treg</td> <td>Normal</td> <td>Moderately increased IgE</td> <td>Recurrent respiratory infections, susceptibility to <em>S. aureus</em>, eczema, hyperextensible joints, scoliosis, arterial dilation in some patients</td> </tr> <tr> <td class="indent1" rowspan="2">Loeys-Dietz syndrome (TGFBR deficiency)</td> <td>Transforming growth factor beta receptor 1 (<em>TGFBR1</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/609192" target="_blank">609192</a></td> <td>Normal</td> <td>Normal</td> <td>Elevated IgE</td> <td>Recurrent respiratory infections, eczema, food allergies, hyperextensible joints, scoliosis, retained primary teeth, aortic aneurysms</td> </tr> <tr> <td>Transforming growth factor beta receptor 2 (<em>TGFBR2</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/610168" target="_blank">610168</a></td> <td>Normal</td> <td>Normal</td> <td>Elevated IgE</td> <td>Recurrent respiratory infections, eczema, food allergies, hyperextensible joints, scoliosis, retained primary teeth, aortic aneurysms</td> </tr> <tr> <td class="indent1">Comel-Netherton syndrome</td> <td>Serine peptidase inhibitor Kazal type 5 (<em>SPINK5</em>) </td> <td>AR</td> <td><a href="https://www.omim.org/entry/605010" target="_blank">605010</a></td> <td>Normal</td> <td>Low switched and nonswitched B cells</td> <td>High IgE and IgA; antibody variably decreased</td> <td>Congenital ichthyosis, bamboo hair, atopic diathesis, increased bacterial infections, failure to thrive</td> </tr> <tr> <td class="indent1">PGM3 deficiency</td> <td>Phosphoglucomutase 3 (<em>PGM3</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/172100" target="_blank">172100</a></td> <td>CD8 and CD4 T cells may be decreased</td> <td>Low B and memory B cells</td> <td>Normal or elevated IgG and IgA; most with high IgE; eosinophilia</td> <td>Severe atopy, autoimmunity, bacterial and viral infections, skeletal anomalies/dysplasia, short stature, brachydactyly, dysmorphic facial features, intellectual disability and cognitive impairment, delayed CNS myelination in some affected individuals</td> </tr> <tr> <td class="indent1">CARD11 deficiency (heterozygous DN)</td> <td>Caspase recruitment domain family member 11 (<em>CARD11</em>)</td> <td>AD LOF</td> <td><a href="https://www.omim.org/entry/617638" target="_blank">617638</a></td> <td>Normal overall but defective T cell activation and proliferation; skewing toward Th2</td> <td>Normal to low</td> <td>High IgE; poor specific antibody production; impaired activation of both NFkB and mTORC1 pathways</td> <td>Variable atopy, eczema, food allergies, eosinophilia; cutaneous viral infections; recurrent respiratory infections; lymphoma; CID</td> </tr> <tr> <td class="subtitle2_left" colspan="8">Defects of vitamin B12 and folate metabolism</td> </tr> <tr> <td class="indent1">Transcobalamin 2 deficiency</td> <td>Transcobalamin 2 (<em>TCN2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/613441" target="_blank">613441</a></td> <td>Normal</td> <td>Variable</td> <td>Decreased</td> <td>Megaloblastic anemia; pancytopenia; if untreated (B12) for prolonged periods, results in intellectual disability</td> </tr> <tr> <td class="indent1">SLC46A1/PCFT deficiency causing hereditary folate malabsorption</td> <td>Solute carrier family 46 member 1 (<em>SLC46A1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/229050" target="_blank">229050</a></td> <td>Variable numbers and activation profile</td> <td>Variable</td> <td>Decreased</td> <td>Megaloblastic anemia; failure to thrive; if untreated for prolonged periods, results in intellectual disability</td> </tr> <tr> <td class="indent1">MTHFD1 deficiency</td> <td>Methylene-tetrahydrofolate dehydrogenase 1 (<em>MTHFD1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/172460" target="_blank">172460</a></td> <td>Low thymic output; normal in vitro proliferation</td> <td>Low</td> <td>Decreased/poor antibody responses to conjugated polysaccharide antigens</td> <td>Recurrent bacterial infection, <em>P. jirovecii</em>, megaloblastic anemia, failure to thrive, neutropenia, seizures, intellectual disability, folate responsive</td> </tr> <tr> <td class="subtitle2_left" colspan="8">Anhidrotic ectodermodysplasia with immunodeficiency (EDA-ID)</td> </tr> <tr> <td class="indent1">EDA-ID due to NEMO/IKBKG efficiency (ectodermal dysplasia, immune deficiency)</td> <td>Inhibitor of NFkB kinase regulatory subunit gamma (<em>IKBKG</em>)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/300248" target="_blank">300248</a></td> <td>Normal or decreased; TCR activation impaired</td> <td>Normal; low memory and isotype switched B cells</td> <td>Decreased; some with elevated IgA and IgM; poor specific antibody responses; absent antibodies to polysaccharide antigens</td> <td>EDA (in some); various infections (bacteria, mycobacteria, viruses, fungi); colitis; conical teeth; variable defects of skin, hair, and teeth; monocyte dysfunction</td> </tr> <tr> <td class="indent1">EDA-ID due to IKBA GOF mutation</td> <td>NFkB inhibitor alpha (<em>NFKBIA</em>)</td> <td>AD GOF</td> <td><a href="https://www.omim.org/entry/164008" target="_blank">164008</a></td> <td>Normal total T cells; TCR activation impaired</td> <td>Normal B cell numbers; impaired BCR activation; low memory an isotype switched B cells</td> <td>Decreased IgG and IgA; elevated IgM; poor specific antibody responses; absent antibodies to polysaccharide antigens</td> <td>EDA; various infections (bacteria, mycobacteria, viruses, fungi); colitis; variable defects of skin, hair, and teeth; T cell and monocyte dysfunction</td> </tr> <tr> <td class="indent1">EDA-ID due to IKBKB GOF mutation</td> <td>Inhibitor of NFkB kinase subunit beta (<em>IKBKB</em>)</td> <td>AD GOF</td> <td><a href="https://www.omim.org/entry/618204" target="_blank">618204</a></td> <td>Decreased T cells; impaired TCR activation</td> <td>Normal number; poor function</td> <td>Reduced</td> <td>Recurrent bacterial, viral, and fungal infections; variable ectodermal defects</td> </tr> <tr> <td class="subtitle2_left" colspan="8">Calcium channel defects</td> </tr> <tr> <td class="indent1">ORAI-1 deficiency</td> <td>ORAI calcium release-activated calcium modulator 1 (<em>ORAI1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/610277" target="_blank">610277</a></td> <td>Normal; defective TCR-mediated activation</td> <td>Normal</td> <td>Normal</td> <td>Autoimmunity, EDA, nonprogressive myopathy</td> </tr> <tr> <td class="indent1">STIM1 deficiency</td> <td>Stromal interaction molecule 1 (<em>STIM1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/605921" target="_blank">605921</a></td> <td>Normal; defective TCR-mediated activation</td> <td>Normal</td> <td>Normal</td> <td>Autoimmunity, EDA, nonprogressive myopathy</td> </tr> <tr> <td class="indent1">CRACR2A</td> <td>Calcium release-activated channel regulator 2A (<em>CRACR2A</em>)</td> <td>AR</td> <td> </td> <td>Mild reduction in T cell numbers</td> <td>Normal</td> <td>Low</td> <td>Later onset; chronic diarrhea; recurrent lower respiratory tract infections, including pneumonia</td> </tr> <tr> <td class="subtitle2_left" colspan="8">Other</td> </tr> <tr> <td class="indent1">PNP deficiency</td> <td>Purine nucleoside phosphorylase (<em>PNP</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/164050" target="_blank">164050</a></td> <td>Progressive decrease</td> <td>Normal</td> <td>Normal or low</td> <td>Autoimmune hemolytic anemia, neurologic impairment</td> </tr> <tr> <td class="indent1">Immunodeficiency with multiple intestinal atresias</td> <td>Tetratricopeptide repeat domain 7A (<em>TTC7A</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/609332" target="_blank">609332</a></td> <td>Variable, but some times absent or low TRECs at NBS; may have SCID phenotype at birth</td> <td>Normal or low</td> <td>Markedly decreased IgG, IgM, and IgA</td> <td>Bacterial (sepsis), fungal, and viral infections; multiple intestinal atresias, often with intrauterine polyhydramnios and early demise</td> </tr> <tr> <td class="indent1" rowspan="2">Tricho-hepato-enteric syndrome (THES)</td> <td>SKI3 subunit of superkiller complex (<em>SKIC3</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/222470" target="_blank">222470</a></td> <td>Impaired IFN-gamma production</td> <td>Variably low numbers of switched memory B cells</td> <td>Hypogammaglobulinemia; may have low antibody responses</td> <td>Respiratory infections, IUGR, facial dysmorphic features, wool hair, earl-onset intractable diarrhea, liver cirrhosis, platelet abnormalities</td> </tr> <tr> <td>SKI2 subunit of superkiller complex (<em>SKIC2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/614602" target="_blank">614602</a></td> <td>Impaired IFN-gamma production</td> <td>Variably low numbers of switched B cells</td> <td>Hypogammaglobulinemia; may have low antibody responses</td> <td>Respiratory infections, IUGR, facial dysmorphic features, wool hair, earl-onset intractable diarrhea, liver cirrhosis, platelet abnormalities</td> </tr> <tr> <td class="indent1">Hepatic veno-occlusive disease with immunodeficiency (VODI)</td> <td>SP110 nuclear body protein (<em>SP110</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/604457" target="_blank">604457</a></td> <td>Normal; decreased memory T cells</td> <td>Normal; decreased memory B cells</td> <td>Decreased IgG, IgA, and IgM; absent germinal enters and tissue plasma cells</td> <td>Hepatic veno-occlusive disease; susceptibility to <em>P. jirovecii</em> pneumonia, CMV, and <em>Candida</em>; thrombocytopenia; hepatosplenomegaly; cerebrospinal leukodystrophy</td> </tr> <tr> <td class="indent1">BCL11B deficiency</td> <td>BAF chromatin remodeling complex subunit BCL11B (<em>BCL11B</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/617237" target="_blank">617237</a></td> <td>Low; poor proliferation</td> <td>Normal</td> <td>Normal</td> <td>Congenital abnormalities, neonatal teeth, dysmorphic facies, absent corpus callosum, neurocognitive deficits</td> </tr> <tr> <td class="indent1">EPG5 deficiency (Vici syndrome)</td> <td>Ectopic P-granules 5 autophagy tethering factor (<em>EPG5</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615068" target="_blank">615068</a></td> <td>Profound depletion of CD4+ cells</td> <td>Defective</td> <td>Decreased (particularly IgG2)</td> <td>Agenesis of the corpus callosum, cataracts, cardiomyopathy, skin hypopigmentation, intellectual disability, microcephaly, recurrent infections, chronic mucocutaneous candidiasis</td> </tr> <tr> <td class="indent1">HOIL1 deficiency</td> <td>RANBP2-type and C3HC4-type zinc finger containing 1 (<em>RBCK1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/610924" target="_blank">610924</a></td> <td>Normal numbers</td> <td>Normal; decreased memory B cells</td> <td>Poor antibody responses to polysaccharides</td> <td>Bacterial infections, autoinflammation, amylopectinosis</td> </tr> <tr> <td class="indent1">HOIP deficiency</td> <td>Ring finger protein 31 (<em>RNF31</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/612487" target="_blank">612487</a></td> <td>Normal numbers</td> <td>Normal; decreased memory B cells</td> <td>Decreased</td> <td>Bacterial infections, autoinflammation, amylopectinosis, lymphangiectasia</td> </tr> <tr> <td class="indent1" rowspan="2">Hennekam-lymphangiectasia-lymphedema syndrome</td> <td>Collagen and calcium binding EGF domains 1 (<em>CCBE1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/612753" target="_blank">612753</a></td> <td>Low/variable</td> <td>Low/variable</td> <td>Decreased</td> <td>Lymphangiectasia and lymphedema with facial abnormalities and other dysmorphic features</td> </tr> <tr> <td>FAT atypical cadherin 4 (<em>FAT4</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/612411" target="_blank">612411</a></td> <td>Low/variable</td> <td>Low/variable</td> <td>Decreased</td> <td>Lymphangiectasia and lymphedema with facial abnormalities and other dysmorphic features</td> </tr> <tr> <td class="indent1">Activating de novo mutations in nuclear factor, erythroid 2-like (NFE2L2)</td> <td>NFE2-like bZIP transcription factor 2 (<em>NFE2L2</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/617744" target="_blank">617744</a></td> <td>Not reported</td> <td>Decreased switched memory B cells</td> <td>Hypogammaglobulinemia; decreased antibody responses</td> <td>Recurrent respiratory and skin infections, grow retardation, developmental delay, white matter cerebral lesions, increased level of homocysteine, increased expression of stress-response genes</td> </tr> <tr> <td class="indent1" rowspan="2">STAT5b deficiency</td> <td rowspan="2">Signal transducer and activator of transcription 5B (<em>STAT5B</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/245590" target="_blank">245590</a></td> <td>Modestly decreased; reduced Treg number and function</td> <td>Normal</td> <td>Hypergammaglobulinemia; increased IgE</td> <td>Growth hormone-insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, prominent autoimmunity</td> </tr> <tr> <td>AD (DN)</td> <td><a href="https://www.omim.org/entry/604260" target="_blank">604260</a></td> <td>Normal</td> <td>Normal</td> <td>Increased IgE</td> <td>Growth failure, eczema, no immune defects compared with AR STAT5 deficiency</td> </tr> <tr> <td class="indent1" rowspan="2">Kabuki syndrome (types 1 and 2)</td> <td>Lysine methyltransferase 2D (<em>KMT2D</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/602113" target="_blank">602113</a></td> <td>Normal</td> <td>Normal</td> <td>Low IgA and occasionally low IgG</td> <td>Typical facial abnormalities, cleft or high arched palate, skeletal abnormalities, short stature, intellectual disability, congenital heart defects, recurrent infections (otitis media, pneumonia) in 50% of patients, autoimmunity may be present</td> </tr> <tr> <td>Lysine demethylase 6A (<em>KDM6A</em>)</td> <td>XL (females may be affected)</td> <td><a href="https://www.omim.org/entry/300128" target="_blank">300128</a></td> <td>Normal</td> <td>Normal</td> <td>Low IgA and occasionally low IgG</td> <td>Typical facial abnormalities, cleft or high arched palate, skeletal abnormalities, short stature, intellectual disability, congenital heart defects, recurrent infections (otitis media, pneumonia) in 50% of patients, autoimmunity may be present</td> </tr> <tr> <td class="indent1">KMT2A deficiency (Wiedemann-Steiner syndrome)</td> <td>Lysine methyltransferase 2A (<em>KMT2A</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/605130" target="_blank">605130</a></td> <td>Normal</td> <td>Decreased switched and nonswitched memory B cells</td> <td>Hypogammaglobulinemia; decreased antibody responses</td> <td>Respiratory infections, short stature, hypertelorism, hair elbows, developmental delay, intellectual disability</td> </tr> <tr> <td class="indent1">DIAPH1 deficiency</td> <td>Diaphanous-related formin 1 (<em>DIAPH1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/616632" target="_blank">616632</a></td> <td>Reduced naïve T cells</td> <td>Decreased memory B cells</td> <td>Low IgM; normal IgG</td> <td>SCBMS; recurrent bacterial, viral, and fungal infections; B lymphoma (3 of 7 patients)</td> </tr> <tr> <td class="indent1">AIOLOS deficiency</td> <td>IKAROS family zinc finger 3 (<em>IKZF3</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/619437" target="_blank">619437</a></td> <td>Normal</td> <td>Reduced; impaired development</td> <td>Very low</td> <td>EBV susceptibility, recurrent sinopulmonary an respiratory infections, <em>P. jirovecii</em>, warts (HPV), <em>Mycobacterium avium</em>, B cell malignancy</td> </tr> <tr> <td class="indent1">CD28 deficiency</td> <td>CD28 molecule (<em>CD28</em>)</td> <td>AR</td> <td> </td> <td>Normal</td> <td>Normal</td> <td>Normal</td> <td>Susceptibility to HPV infection only</td> </tr> </tbody></table></div><div class="graphic_lgnd">Total number of mutant genes in table: 69.</div><div class="graphic_footnotes">IUIS: International Union of Immunological Societies; 
    LOF: loss of function; 
    XL: X linked;
    CD: cluster of differentiation; 
    IgM: immunoglobulin M; 
    IgA: immunoglobulin A; 
    IgE: immunoglobulin E; 
    WIP: WASP interacting protein; 
    AR: autosomal recessive; 
    ANA: antinuclear antibody; 
    ANCA: antineutrophil cytoplasmic antibody; 
    DNA: deoxyribonucleic acid; 
    IEI: inborn errors of immunity; 
    TREC: T cell receptor excision circle; 
    NBS: newborn screening; 
    IgG: immunoglobulin G; 
    PHA: phytohemagglutinin; 
    NK: natural killer; 
    EBV: Epstein-Barr virus; 
    HSV: herpes simplex virus; 
    VZV: varicella-zoster virus; 
    GI: gastrointestinal; 
    FILS: facial dysmorphism, immunodeficiency, livedo, and short stature; 
    BCG: Bacillus Calmette-Guérin; 
    RBC: red blood cell; 
    IUGR: intrauterine growth restriction; 
    CMV: cytomegalovirus; 
    HLH: hemophagocytic lymphohistiocytosis; 
    AD: autosomal dominant; 
    CHARGE: coloboma of the eye, heart anomalies, choanal atresia, retardation, genital and ear anomalies; 
    CNS: central nervous system; 
    SCID: severe combined immunodeficiency; 
    RNA: ribonucleic acid; 
    MOPD1: microcephalic osteodysplastic primordial dwarfism type 1; 
    STAT: signal transducer and activator of transcription; 
    DN: dominant negative; 
    Th17: T helper type 17; 
    MAIT: mucosal-associated invariant T; 
    NKT: natural killer T; 
    Treg: regulatory T cells; 
    BAFF: B cell activating factor; 
    IL: interleukin; 
    Th2: T helper type 2; 
    NFkB: nuclear factor kappa B; 
    mTORC1: mechanistic (mammalian) target of rapamycin complex 1; 
    PCFT: proton-coupled folate transporter; 
    EDA: anhidrotic ectodermodysplasia; 
    NEMO: NFkB essential modulator; 
    TCR: T cell receptor; 
    IKBA: I-kappa-B alpha; 
    GOF: gain of function; 
    BCR: B cell receptor; 
    IFN: interferon; 
    HOIL1: heme-oxidized IRP2 ubiquitin ligase 1; 
    HOIP: HOIL-1-interacting protein; 
    SCBMS: seizures, cortical blindness, microcephaly syndrome; 
    HPV: human papillomavirus.</div><div class="graphic_reference">From: Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022; 42:1473. Copyright © 2022 The Authors. Reproduced under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License 4.0</a>.</div><div id="graphicVersion">Graphic 139940 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
